Capsule for convalescent hepatitis syndrome

A technology for hepatitis syndrome and capsules, which is applied in the directions of capsule delivery, drug combination, medical preparations containing active ingredients, etc., can solve the problems of slow onset and low efficiency, and achieve the effect of inhibiting increase

Inactive Publication Date: 2014-06-04
李明寿
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Treatment based on the premise of tonifying deficiency leads to low efficiency and slow onset of effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Capsule for convalescent hepatitis syndrome

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Example 1, the weight ratio of raw materials: 20 parts of Qingxianggui, 10 parts of pumpkin vine, 6 parts of triangular grass, 10 parts of acacia, 6 parts of bobbin, 10 parts of saddle rattan, 10 parts of Pittosporum bark, 10 parts of Pittonia chinensis, 10 parts of Guiding, 2 parts of willow moss, 6 parts of mulberries, 20 parts of mulberry.

[0032] The preparation method of embodiment 1 is: mix osmanthus osmanthus, pumpkin vine, triangle grass, acacia, bobbin, saddle rattan, Pittogonia bark, scallops, osmanthus cinnamon, willow moss, mulberries, and mulberries, and add water to decoct, Take the filtrate after 30 minutes, add water to the dregs of the medicine and continue to decoct for 20 minutes, then take the filtrate, combine the two filtrates, divide into two parts and take it in the morning and evening.

Embodiment 2

[0033] Embodiment 2, raw material medicine weight ratio: 10 parts of cinnamon osmanthus, 6 parts of pumpkin vines, 3 parts of triangular grass, 6 parts of saponins, 3 parts of bobbins, 6 parts of saddle rattan, 6 parts of Pittodia bark, 6 parts of Spleenia chinensis, 6 parts of Guiding, 1 part of willow leaf moss, 3 parts of mulberries, and 10 parts of mulberry.

Embodiment 3

[0034] Example 3, the weight ratio of raw materials: 20 parts of Qingxianggui, 10 parts of pumpkin vine, 6 parts of triangular grass, 10 parts of acacia, 6 parts of bobbin, 10 parts of saddle rattan, 10 parts of Pittosporum bark, 10 parts of Pittonia chinensis, 10 parts of Guiding, 2 parts of willow moss, 6 parts of mulberries, 20 parts of mulberry.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a capsule for a convalescent hepatitis syndrome, and aims at solving the problem of treatment of a post-hepatitis syndrome. The capsule is characterized in that a preparation method comprises the following steps: (1) respectively extracting volatile oil from erythrina bark, cushaw stems, tetrapanax papyriferum, beach morningglory herb, cassiabarktree fruit and climbing fig coarse powder through steam distillation, collecting, then mixing for later use, and collecting medicine residues for later use; (2) uniformly mixing sarcococca ruscifolia, loranthus parasiticus, smallflower bracketplant herb, gleditsia sinensis, amblystegium serpens, fructus mori and the medicine residues obtained from the step (1), and carrying out water extraction and alcohol precipitation to obtain an initial material after a supernatant is dried; and (3) spraying the volatile oil into the initial material, screening through a sieve with the mesh size of 60, and packaging the capsule. A clinical experiment proves that the capsule disclosed by the invention has the characteristics of good treatment effect and higher safety on treating the post-hepatitis syndrome and is worthy to be clinically applied and popularized.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a capsule for convalescent hepatitis syndrome. Background technique [0002] Post-Hepatitis Syndrome (Post-Hepatitis Syndrome, PHS) is a syndrome characterized by autonomic disorder after healing from viral hepatitis, also known as Convalescent Hepatitis Syndrome. Since the disease is a functional change after hepatitis, there is no positive test result to support the evidence of continued liver inflammation, so the current clinical reason for the disease is only inferred to be related to the autonomic disorder after the hepatitis has healed. [0003] The treatment of PHS has always been a difficult point in the treatment of liver diseases, often only by taking negative symptomatic treatment for autonomic dysfunction, such as using B vitamins, vitamin C, oryzanol, eleuthero and other drugs, but due to the relationship between the disease and autonomic nerve function T...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8988A61K9/48A61P1/16
Inventor 孙峰
Owner 李明寿
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap